Sandwich, UK — 25 March 2026: Discovery Park, Kent’s science and innovation hub, has launched the sixth edition of its Discovery Spark accelerator programme, welcoming 11 startups to its campus in Sandwich.
The business growth programme has already supported 50 companies and 76 founders, with alumni securing £5.5m in UKRI funding since launching in 2023. For Cohort 6.0, the startups were selected based on the need for their innovation, the uniqueness of their solution, and the strength of their team. Spark is designed to provide opportunities for companies to grow a network of peers,…
Amsbio announce the RPMotion – a spinning organoid bioreactor that facilitates fast, easy and efficient organoid culture for drug discovery, disease modelling and regenerative medicine.
Until now organoid expansion has been an expensive and time-consuming static process, requiring large amounts of materials, skilled labour and time. Benefiting from a novel bioreactor design – the RPMotion – overcomes current limitations in organoid expansion / differentiation methodologies, helping laboratories improve efficiency and reduce reliance on manual processes.…
LONDON, UK, March 18, 2026 / Biotech Newswire / -- Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of Touchlight’s proprietary doggybone DNA™ (dbDNA™). This linear, covalently closed, double-stranded DNA format offers researchers a fast, cell-free alternative to traditional plasmid DNA, supporting the growing demand for nucleic acid therapeutics.
Traditional plasmid manufacturing remains a critical bottleneck for advanced therapy developers, often…
• Cutting-edge platform technology leveraging advanced molecular dynamics to uncover protein metastates and reveal novel binding sites in difficult to target proteins.
• Combining RxPlorer™ with our in vitro capabilities, RxCelerate can deliver rapid hit identification and screening in 2 months.
Cambridge, UK and Cambridge, MA – 24/3/26 1pm GMT
RxCelerate, a leading international outsourced drug discovery and development provider, today announced the launch of RxPlorer™: a new technology for finding small molecule hits, particularly against challenging, previously undruggable targets.…
We are pleased to announce the winners of the One Nucleus Awards 2026! The awards took place on 29 March in London.The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision and enabling support across the stakeholders.
Many congratulations to the winners and finalists:
Best Therapeutic R&D Programme of the Year⭐Winner: Resolution Therapeutics⭐Finalists: Serenatis Bio, TRIMTECH Therapeutics
Best Use of Emerging Technology of the Year⭐Winner: Nuclera⭐Finalists: Ignota Labs, Constructive Bio
Best Industry and Not-for-Profit…
New parliamentary scrutiny of the UK’s innovation landscape has reinforced longstanding concerns about how investment in innovation is distributed across the country, with Pioneer Group, a specialist in technology infrastructure and venture building, urging swift action to address persistent barriers to research commercialisation.
The Science, Innovation and Technology Committee’s report emphasises that the UK is “flying blind” when it comes to public and private R&D spending, with major R&D funders unable to properly measure and map levels of investment, their outputs, and regional…
— Financing brings total funds committed to date to >$95 million
— Proceeds support the STARLYS clinical trial evaluating targeted LTBR agonist MST-0312 in solid tumors, together with platform and pipeline activities in inflammatory diseases
— Expands the leadership team with exceptional development executives to propel the clinical advancement of the pipeline
Cambridge, UK, March 17, 2026 – Mestag Therapeutics (“Mestag”), a biotech company harnessing fibroblast immunology to develop impactful treatments for patients with cancer and inflammatory diseases, today announced the closing of a $…
Free-to-use software version available for academic and non-profit researchers worldwide
Intuitive system provides robust data management tools to support scientific collaboration and engagement with funding bodies through streamlined adherence to FAIR data principles
Silverstone, UK, 16 March 2026: Lab Thread Ltd, a UK-based life science software company, today announced the release of a free of charge version of the Company’s Unified Lab Software Platform, available to academic and non-profit researchers worldwide. The software provides a range of core modules tailored to support early-…
Penningtons Manches Cooper has partnered with Beauhurst, a leading private company data platform, to launch its latest report on the UK spinouts landscape, Investment into Spinouts 2026.
The publication offers a comprehensive overview of investment into UK spinouts, including trends in equity deployment, grant funding, regional performance and sector level dynamics.
It highlights the continued strength of the UK’s ‘Golden Triangle’ universities, with Cambridge, Oxford and London again securing the highest levels of spinout investment. It also examines the rise of early stage dealmaking, the…
Wes Streeting, Secretary of State for Health and Social Care Marks Official Launch of Health Innovation Hub
Glasgow’s newest purpose-built life sciences laboratory facility, the Health Innovation Hub (HiH), has been officially opened by Wes Streeting, Secretary of State for Health and Social Care following a launch event (5 March). This marks a major milestone for Scotland’s life sciences and the healthcare innovation ecosystem in Glasgow City Region.
Developed and operated by Kadans Science Partner, in collaboration with the University of Glasgow’s Living Laboratory for Precision Medicine,…